Back to Journals » Therapeutics and Clinical Risk Management » Volume 11
Perspectives
Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
17,506 | Dovepress* | 15,159+ | 2,283 | 17,442 | |
PubMed Central* | 2,347 | 522 | 2,869 | ||
Totals | 17,506 | 2,805 | 20,311 | ||
*Since 26 February 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar